Document Type : Original Article


1 ‎Assistant Professor of Pediatric Infectious Disease, Department of Pediatrics, School ‎of Medicine, Emam Khomeini Hospital, Ilam University of Medical sciences, Ilam, Iran

2 ‎Assistant Professor of Dermatology, Department of Dermatology, School of ‎Medicine, Emam Khomeini Hospital, Ilam University of Medical sciences, Ilam, Iran

3 ‎Department of Paramedical, School of Allied Medical Sciences, Ilam University of Medical ‎Sciences, Ilam, Iran ‎


Background and Objective: Vaccines are medical devices used for boosting the health of people, especially children. This study was performed to determine the prevalence of the side effects of a new pentavalent vaccine in 2- to 6-month-old children in Ilam.
Materials and Methods: This descriptive cross-sectional study was performed on 2-6-month-old children for inoculating the pentavalent vaccine. A questionnaire containing queries on the age of child, parents’ education, contact number, injection date, gestational age, the underlying diseases, failure to thrive (FTT), and side effects (diarrhea, vomiting, nausea, redness, fever, intense crying, restlessness, drowsiness, stiffness, etc.).
Results: Of the children, 35.9% were two months old, 31.8% were four months old, and 32.3% were six months old. Boys and girls constituted 53% and 47% of children, respectively. Regarding mothers’ education, 54.5% had lower than diploma degrees, and 6.1% had academic education. Regarding fathers’ education, 13.2% had lower than diploma, and 12% had academic degrees. Most of the children (94.4%) had no underlying diseases, and 5.6% of them suffered from the underlying diseases including reflux (1.6%), anemia (2.3%), favism (0.9%), fever and convulsion (0.7%), and hypothyroidism (0.2%). The most common complications were fever (68.1%), skin redness (56.1%), pain (43.8%), and restlessness (24.7%). Fever (69.2% vs. 66.8%, P>0.05), skin redness (65.2% vs. 45.8%, P<0.05), vomiting (10.5% vs. 3.3%, P<0.05), and stiffness (6.6% vs. 3.3%, P>0.05) were more common in boys than girls, respectively. On the other hand, restlessness (35.8% vs. 14.8%, P<0.05) was significantly higher in girls than in boys.
Conclusion: According to our results, fever, skin redness, and pain were the most common complications. Fever was more common in 2-month-old boys, and pain was more observed in 6-month-old girls. Most of the side effects were transient and disappeared upon a week. No remarkable contraindications were reported, confirming the safety of the vaccine.

Graphical Abstract

An Investigation on Prevalence of Side Effects of a ‎New Pentavalent Vaccine in Two-to Six-Month-Old ‎Children Referred to Health Centers in Ilam City ‎


Main Subjects

  1. Shokri M, Nayyeri S, Salimi N, Nourmohammadi A, Tarjoman A, Borji M, Kalvandi G, Mahdikhani S. (2021). Prevalence of Neonatal Birth Trauma in Iran: a Systematic Review and Meta-Analysis. Int J Pediatr., 9(10): 14520-14531. [Crossref], [Google Scholar], [Publisher]
  2. Shokri M, Afsharloo S, Tarjoman A, Borji M, Mahdikhani S, Maleki M, Zarei F, Meisami A. (2021). Dental Trauma among Iranian Children and Adolescents: A Comprehensive Study. Int J Pediatr., 9(1): 12901-12908. [Crossref], [Google Scholar], [Publisher]
  3. Reczulska A, Tomaszewska A, Raciborski F J V. (2022). Level of Acceptance of Mandatory Vaccination and Legal Sanctions for Refusing Mandatory Vaccination of Children. Vaccines., 10(5): 811. [Crossref], [Google Scholar], [Publisher]
  4. Versteegen P, Pinto M V, Barkoff A M, van Gageldonk P G, van de Kassteele J, van Houten M A, Sanders E A, de Groot R, Diavatopoulos D A, Bibi S J E. (2021). Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom. Ebio Medicine., 65: 103247. [Crossref], [Google Scholar], [Publisher]
  5. Hatami H, Arshi S, Shafiei Ganjeh T, Sarikhani R. (2016). Prevalence rate of early adverse reactions following pentavalent vaccination in infants aging from 2 to 6 months in Tehran and Damavand city-2015., Journal of Medical Council of I.R.I., 34(2): 138-142. [Google Scholar], [Publisher]
  6. Ekrami Noghabi M, Saffar M J, Rezai S, Saffar H, Saffar H, Hosseinzadeh F, Nadi Ghara A, Rezai M S. (2021). Immunogenicity and complications of the pentavalent vaccine in Iranian children. Front Pediatr. 1049. [Crossref], [Google Scholar], [Publisher]
  7. Khazaei Z, Moradi G, Zahraei S M, Gouya M M, Goodarzi E, Yaghini F, Roshani D. (2020). The comparison of the adverse events of pentavalent vaccine and dpt vaccine in 2–6 onths infants in Iran: A national study. Ann Glob Health., 86 (1) [Crossref], [Google Scholar], [Publisher]
  8. Lewnard J A, Fries L F, Cho I, Chen J, Laxminarayan R., (2022). Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus. Proc Natl Acad Sci U S A., 119(12): e2112410119. [Crossref], [Google Scholar], [Publisher]
  9. Li G, Finn A, Pollard A J. (2021). Should we be vaccinating children against COVID-19 in high-income countries? Expert Review of Vaccines., 20(9): 1043-1046. [Crossref], [Google Scholar], [Publisher]
  10. Christie A, Brooks J T, Hicks L A, Sauber-Schatz E K, Yoder J S, Honein M. A. (2021). Guidance for implementing COVID-19 prevention strategies in the context of varying community transmission levels and vaccination coverage. MMWR Morb Mortal Wkly Rep., 70(30): 1044. [Crossref], [Google Scholar], [Publisher]
  11. Berangi Z, Karami M, Mohammadi Y, Nazarzadeh M, Zahraei S M, Javidrad H, Heidari S. (2019). Epidemiological profile of meningitis in Iran before pentavalent vaccine introduction. BMC Pediatrics., 19(1): 1-9. [Google Scholar], [Publisher]
  12. Karami M, Ameri P, Bathaei J, Berangi Z, Pashaei T, Zahiri A, Zahraei S M, Erfani H, Ponnet K. (2017). Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran. BMC Immunol., 18(1): 1-7. [Crossref], [Google Scholar], [Publisher]
  13. Heidari S, Karami M, Zahraei S M, Sedighi I, Zavareh F A. (2021). Epidemiological Profile of Meningitis following Pentavalent Vaccination in Iran: Impact of Vaccine Introduction. J Epidemiol Glob Health., 11(3): 310. [Crossref], [Google Scholar], [Publisher]
  14. Karami M, Zahraei S M, Gouya M M. (2015). Perspective of Iranian vaccine-preventable diseases surveillance system in the era of newly introduced pentavalent vaccine: possibility of implementing a sentinel hospital-based surveillance system. Iran J Public Health., 44(12), 1712. [Google Scholar], [Publisher]
  15. Hatami H, Arshi S, Sarikhani R, (2016). The relationship between side effects of the Pentavalent vaccine and mother's education level in areas under the auspices of Shahid Beheshti University of Medical Sciences in 2015. [Google Scholar], [Publisher]
  16. Rosen B, Waitzberg R, Israeli A, Hartal M, Davidovitch N. (2021). Addressing vaccine hesitancy and access barriers to achieve persistent progress in Israel’s COVID-19 vaccination program. Isr J Health Policy Res., 10(1): 1-20. [Google Scholar], [Publisher]
  17. Küçükali H, Ataç Ö, Palteki A S, Tokaç A Z, Hayran O J V. (2022). Vaccine hesitancy and anti-vaccination attitudes during the start of COVID-19 vaccination program: a content analysis on twitter data. Vaccines., 10(2): 161. [Crossref], [Google Scholar], [Publisher]
  18. Mesher D, Panwar K, Thomas S L, Edmundson C, Choi Y H, Beddows S, Soldan K. (2018). The impact of the national HPV vaccination program in England using the bivalent HPV vaccine: surveillance of type-specific HPV in young females, 2010–2016. The Journal of Infectious Diseases., 218(6): 911-921. [Crossref], [Google Scholar], [Publisher]
  19. Maertens K, Leuridan E, Munoz F M, Zimmermann P, Curtis N, Halperin S, Rots N, Barug D, Holder B, Sadarangani M, Abu-Raya B. (2022). Impact of vaccination during pregnancy on infants’ immune responses to vaccinations-definitions and statistical approaches. Vaccine., 40(32): 4292–4295. [Crossref], [Google Scholar], [Publisher]
  20. Rezza G. (2019). Mandatory vaccination for infants and children: the Italian experience. Pathogens and Global Health., 113(7): 291-296. [Crossref], [Google Scholar], [Publisher]